References (continued)
FDA 510K premarket notification. Devon Medical Products extriCARE™
2400. Class II device. January 1, 2012
FDA Consumer Health Information. Negative Pressure Wound Devices Draw
FDA Notice, Advice. December 2009
FDA. Medical Device Safety. Alerts and Notices. FDA Preliminary Public
Health Notification: Serious Complications Associated with Negative
Pressure Wound Therapy Systems. November 13, 2009.
Gupta S. et al. Guidelines for Managing Pressure Ulcers with Negative
Pressure Wound Therapy. Advances in Skin and Wound Care. 2004; 17: 1-16
Kirby M. Negative Pressure Wound Therapy. British Journal of Diabetes &
Vascular Disease. 2007;7:230
Miller M. Commentary: New Microvascular Blood Flow Research Challenges
Practice Protocols in Negative Pressure Wound Therapy. Wounds. 2005; 10
Morykwas MJ. et al. Vacuum Assisted Closure: A New Method for Wound
Control and Treatment: animal studies and Basic Foundation. Annals of
Plastic Surgery. 1997; 38: 553-562
Thompson J, Marks M. Negative Pressure Wound Therapy. Clinics in Plastic
Surgery. 2007; 34(4): 673-684
22
Содержание extriCARE 2400
Страница 24: ...www devonmedicalproducts com 866 446 0092...